Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1985 1
1986 3
1988 1
1990 2
1991 3
1992 1
1994 3
1995 1
1996 4
1997 1
1998 1
1999 4
2001 3
2002 13
2003 11
2004 10
2005 16
2006 13
2007 15
2008 22
2009 19
2010 23
2011 20
2012 26
2013 35
2014 36
2015 17
2016 15
2017 20
2018 20
2019 14
2020 19
2021 16
2022 10
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 18594322

377 results

Results by year

Filters applied: . Clear all
Page 1
Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International Expanded Access Program.
Santoro A, O'Brien ME, Stahel RA, Nackaerts K, Baas P, Karthaus M, Eberhardt W, Paz-Ares L, Sundstrom S, Liu Y, Ripoche V, Blatter J, Visseren-Grul CM, Manegold C. Santoro A, et al. J Thorac Oncol. 2008 Jul;3(7):756-63. doi: 10.1097/JTO.0b013e31817c73d6. J Thorac Oncol. 2008. PMID: 18594322 Free article. Clinical Trial.
Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program.
Taylor P, Castagneto B, Dark G, Marangolo M, Scagliotti GV, van Klaveren RJ, Labianca R, Serke M, Schuette W, van Meerbeeck JP, Heigener D, Liu Y, Adachi S, Blatter J, von Pawel J. Taylor P, et al. J Thorac Oncol. 2008 Jul;3(7):764-71. doi: 10.1097/JTO.0b013e31817c73ec. J Thorac Oncol. 2008. PMID: 18594323 Free article.
Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
Obasaju CK, Ye Z, Wozniak AJ, Belani CP, Keohan ML, Ross HJ, Polikoff JA, Mintzer DM, Monberg MJ, Jänne PA; Pemetrexed Expanded Access Program Investigators. Obasaju CK, et al. Lung Cancer. 2007 Feb;55(2):187-94. doi: 10.1016/j.lungcan.2006.09.023. Epub 2006 Nov 7. Lung Cancer. 2007. PMID: 17092602
Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma.
Ceresoli GL, Zucali PA, Favaretto AG, Grossi F, Bidoli P, Del Conte G, Ceribelli A, Bearz A, Morenghi E, Cavina R, Marangolo M, Parra HJ, Santoro A. Ceresoli GL, et al. J Clin Oncol. 2006 Mar 20;24(9):1443-8. doi: 10.1200/JCO.2005.04.3190. J Clin Oncol. 2006. PMID: 16549838 Clinical Trial.
Pemetrexed: a multitargeted antifolate.
Rollins KD, Lindley C. Rollins KD, et al. Clin Ther. 2005 Sep;27(9):1343-82. doi: 10.1016/j.clinthera.2005.09.010. Clin Ther. 2005. PMID: 16291410 Review.
377 results